HIV-drug Gammora may eliminate 99% of the HIV virus within four weeks of treatment, according to the results of a Phase 1/2a clinical trial, conducted by Israeli biotech Zion Medical.
The synthetic peptide compound, derived from the HIV enzyme integrase, proved safe and effective in killing HIV-infected cells, thus reaffirming the results of prior preclinical tests looking into the effectiveness of the drug as a cure for HIV.
